Ledger.Open graph →

SEC Form D · Amendment · filed June 22, 2020

Bryn Pharma, LLC

Offering

$35.0M

Sold

$26.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

RALEIGH, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Lisa Licht · Raleigh, NCDirector Michelle Lobel · Raleigh, NCExec · Director Kate Grell · Raleigh, NCDirector Dale Sander · Raleigh, NCExec Stephen Beckman · Raleigh, NCExec Steven Hartman · Raleigh, NCExec · Director David Dworaczyk · Raleigh, NCExec · Director Marc Rapaport · Raleigh, NCDirector Farah Rehman · Houston, TXExec Martin Devenport · Rockville, MDExec · Director Rajul Garg · Singapore, U0Exec · Director Luke R. Wood · Austin, TXDirector Miao Hong · Rockville, MDDirector Judah Drillick · NEW YORK, NYDirector Avrohom G. Vann · Evanston, ILExec Kun-Liang Guan · Rockville, MDExec · Director Swan E. Sit · EMERYVILLE, CAExec · Director Xiaopei (Ray) Wang · EMERYVILLE, CAExec · Director Yenyou (Jeff) E. Zheng · EMERYVILLE, CADirector Paul E. Freiman · EMERYVILLE, CAExec Andrew M. Jones · EMERYVILLE, CAExec · Director Jeffrey Thompson · Newport, RIExec Regina Kirch · Dover, DEDirector Jackson Moses · Dover, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗